Confronting the next pandemic-Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010

This publication has 21 references indexed in Scilit:

• Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain
  Vaccine, 2011
• Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences
  Vaccine, 2010
• Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China
  Biologicals, 2010
• A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide
  Nature Protocols, 2009
• Proteomics‐based characterization of hemagglutinins in different strains of influenza virus
  Proteomics – Clinical Applications, 2009
• Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins
  Vaccine, 2008
• Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry
  Vaccine, 2008
• Selective and Quantitative Detection of Influenza Virus Proteins in Commercial Vaccines Using Two-Dimensional High-Performance Liquid Chromatography and Fluorescence Detection
  Analytical Chemistry, 2007
• Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans
  PLOS Medicine, 2007
• Summary of Clinical Trials of Inactivated Influenza Vaccine--1978
  Clinical Infectious Diseases, 1983